(Q40878942)

reason for preferred rank

24 September 2017

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

24 June 2022

Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

0 references

Schneider JC Jr

3

1 reference

24 September 2017

A. E. Dorr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

K. Gundersen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

J. C. Schneider

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

T. W. Spencer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

W. B. Martin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A346598

24 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=346598

24 June 2022

publication date

1 January 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0021968178900760?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

https://api.elsevier.com/content/article/PII:0021968178900760?httpAccept=text/plain

24 June 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Journal of Chronic Diseases

24 June 2022

published in

1 reference

24 September 2017

31

1 reference

24 September 2017

5-14

1 reference

24 September 2017

1

1 reference

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

24 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Coronary heart disease in seven countries

3 April 2023

2

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Epidemiology of Coronary Heart Disease

3 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Risk factors for myocardial infarction and death due to ischemic heart disease and other causes

3 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Clinical biostatistics. 18. The clofibrate trials: another dispute about contratrophic therapy.

3 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Clofibrate in ischemic heart disease

3 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Should Hyperlipoproteinemia Be Treated In Patients With Coronary Artery Disease?

3 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man

3 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

A simplified semiautomated assay for plasma triglycerides

3 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Maximum utilization of the life table method in analyzing survival

3 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Colestipol and clofibrate in hypercholesterolemia

3 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol

3 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Interruption of the enterohepatic circulation of bile acids in man: comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism

3 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Cholestyramine in type II hyperlipoproteinemia. A double-blind trial

3 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

Atherosclerotic cardiovascular disease: current prospectives

3 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0021-9681(78)90076-0

3 April 2023

Identifiers

1 reference

24 September 2017

1 reference